Recommend 31st July 2026
This page does not identify a published human intervention trial establishing safety, pharmacokinetics, dosing, weight-loss efficacy, metabolic benefit, anti-aging activity, or NAD + enhancement in people
P values less than 0.05 were considered statistically significant
Equipment and Supplies Successful BPC-157 administration requires appropriate supplies
GHK-Cu and Infection-Related Readouts in Wound Contexts Mouse and clinical datasets point to a possible reduction in inflammatory proteases (for example, MMP-2/9) and cytokines (such as TNF-) in wounds exposed to GHK-Cu, aligning with lower observed infection rates in comparative ulcer care cohorts
While the injections start working immediately, it may take a few days to weeks to notice significant improvements in symptoms